HomeMCRB • NASDAQ
add
Seres Therapeutics Inc
Previous close
$0.85
Day range
$0.83 - $0.91
Year range
$0.54 - $1.53
Market cap
144.15M USD
Avg Volume
2.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.22M | -34.20% |
Net income | 88.78M | 285.51% |
Net profit margin | — | — |
Earnings per share | -0.33 | 10.81% |
EBITDA | -27.77M | 35.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 66.82M | -60.67% |
Total assets | 178.74M | -51.39% |
Total liabilities | 154.82M | -59.56% |
Total equity | 23.92M | — |
Shares outstanding | 170.74M | — |
Price to book | 6.07 | — |
Return on assets | -29.14% | — |
Return on capital | -60.00% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 88.78M | 285.51% |
Cash from operations | -34.68M | 41.47% |
Cash from investing | 141.14M | 7,954.37% |
Cash from financing | -110.87M | -7,783.37% |
Net change in cash | -4.41M | 92.61% |
Free cash flow | 18.02M | 143.78% |
About
CEO
Founded
2010
Website
Employees
233
